Clinical Trial Update: Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial compares tab.Labetalol with tab.Nifedipine for postpartum hypertension; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hypertension

Drugs mentioned

• Tab.Labetalol (labetalol)
• Tab.Nifedipine (nifedipine)

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Postnatal Hypertension | Phase 3 | Status: UNKNOWN